Retroviral restriction and dependency factors in primates and carnivores

Veterinary Immunology and Immunopathology

Volumn 143, Issue 3-4, 2011, Pages 179-189

  Fadel, Hind J ^a   Poeschla, Eric M ^a  

^a Mayo Clinic   (United States)

Author keywords

AIDS; APOBEC3; Carnivores; FIV; HIV 1; Lentivirus; Restriction factor; TRIM5 ; TRIMCyp

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CHEMOKINE RECEPTOR CXCR4; CYCLOPHILIN A; TRIPARTITE MOTIF PROTEIN 5;

CARNIVORE; FELINE FOAMY VIRUS; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR CLONING; NONHUMAN; PRIMATE; PROTEIN EXPRESSION; REVIEW; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS EXPRESSION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS UNCOATING;

ANIMALS; CARNIVORA; CATS; DISEASE MODELS, ANIMAL; DOGS; HIV INFECTIONS; HIV-1; LENTIVIRUS; LENTIVIRUS INFECTIONS; MICE; PRIMATE DISEASES; PRIMATES; RABBITS; RATS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LENTIVIRUSES; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; PRIMATES;

EID: 80052363221     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.06.002     Document Type: Review

References (170)

1. Ackley C.D., Yamamoto J.K., Levy N., Pedersen N.C., Cooper M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 1990, 64:5652-5655.
2. Ambrose Z., KewalRamani V.N., Bieniasz P.D., Hatziioannou T. HIV/AIDS: in search of an animal model. Trends Biotechnol. 2007, 25:333-337.
3. Anderson J.L., Campbell E.M., Wu X., Vandegraaff N., Engelman A., Hope T.J. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J. Virol. 2006, 80:9754-9760.
4. Antunes A., Troyer J.L., Roelke M.E., Pecon-Slattery J., Packer C., Winterbach C., Winterbach H., Hemson G., Frank L., Stander P., Siefert L., Driciru M., Funston P.J., Alexander K.A., Prager K.C., Mills G., Wildt D., Bush M., O'Brien S.J., Johnson W.E. The evolutionary dynamics of the lion Panthera leo revealed by host and viral population genomics. PLoS Genet. 2008, 4:e1000251.
5. Asaoka K., Ikeda K., Hishinuma T., Horie-Inoue K., Takeda S., Inoue S. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 2005, 338:1950-1956.
6. Bartee E., McCormack A., Fruh K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2006, 2:e107.
7. Baumann J.G., Unutmaz D., Miller M.D., Breun S.K., Grill S.M., Mirro J., Littman D.R., Rein A., KewalRamani V.N. Murine T cells potently restrict human immunodeficiency virus infection. J. Virol. 2004, 78:12537-12547.
8. Bieniasz P.D. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 2004, 5:1109-1115.
9. Bieniasz P.D., Cullen B.R. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 2000, 74:9868-9877.
10. Bishop K.N., Holmes R.K., Malim M.H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 2006, 80:8450-8458.
11. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.J., Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 2004, 14:1392-1396.
12. Bishop K.N., Verma M., Kim E.Y., Wolinsky S.M., Malim M.H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 2008, 4:e1000231.
13. Bosco D.A., Eisenmesser E.Z., Pochapsky S., Sundquist W.I., Kern D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:5247-5252.
14. Brennan G., Kozyrev Y., Hu S.L. TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3569-3574.
15. Broussard S.R., Staprans S.I., White R., Whitehead E.M., Feinberg M.B., Allan J.S. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 2001, 75:2262-2275.
16. Campbell E.M., Perez O., Anderson J.L., Hope T.J. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J. Cell Biol. 2008, 180:549-561.
17. Carthagena L., Parise M.C., Ringeard M., Chelbi-Alix M.K., Hazan U., Nisole S. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology 2008, 5:59.
18. Conticello S.G., Harris R.S., Neuberger M.S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 2003, 13:2009-2013.
19. Daniel M.D., Letvin N.L., King N.W., Kannagi M., Sehgal P.K., Hunt R.D., Kanki P.J., Essex M., Desrosiers R.C. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985, 228:1201-1204.
20. Diaz-Griffero F., Kar A., Lee M., Stremlau M., Poeschla E., Sodroski J. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 2007, 369:400-410.
21. Diaz-Griffero F., Li X., Javanbakht H., Song B., Welikala S., Stremlau M., Sodroski J. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 2006, 349:300-315.
22. Diaz-Griffero F., Vandegraaff N., Li Y., McGee-Estrada K., Stremlau M., Welikala S., Si Z., Engelman A., Sodroski J. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 2006, 351:404-419.
23. Dietrich I., Macintyre A., McMonagle E., Price A.J., James L.C., McEwan W.A., Hosie M.J., Willett B.J. Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion. J. Virol. 2010, 84:8980-8985.
24. Doehle B.P., Schafer A., Wiegand H.L., Bogerd H.P., Cullen B.R. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 2005, 79:8201-8207.
25. Elder J.H., Lin Y.C., Fink E., Grant C.K. Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr. HIV Res. 2010, 8:73-80.
26. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 1996, 272:872-877. (see comments).
27. Fletcher A.J., Hue S., Schaller T., Pillay D., Towers G.J. Hare TRIM5alpha restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genes. J. Virol. 2010, 84:12463-12468.
28. Gao F., Bailes E., Robertson D.L., Chen Y., Rodenburg C.M., Michael S.F., Cummins L.B., Arthur L.O., Peeters M., Shaw G.M., Sharp P.M., Hahn B.H. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999, 397:436-441.
29. Gifford R.J., Katzourakis A., Tristem M., Pybus O.G., Winters M., Shafer R.W. A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20362-20367.
30. Gilbert C., Maxfield D.G., Goodman S.M., Feschotte C. Parallel germline infiltration of a lentivirus in two Malagasy lemurs. PLoS Genet. 2009, 5:e1000425.
31. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 1996, 273:231-235.
32. Goffinet C., Allespach I., Homann S., Tervo H.M., Habermann A., Rupp D., Oberbremer L., Kern C., Tibroni N., Welsch S., Krijnse-Locker J., Banting G., Krausslich H.G., Fackler O.T., Keppler O.T. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 2009, 5:285-297.
33. Goffinet C., Schmidt S., Kern C., Oberbremer L., Keppler O.T. Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J. Virol. 2010, 84:11374-11384.
34. Guo F., Cen S., Niu M., Yang Y., Gorelick R.J., Kleiman L. The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA. J. Virol. 2007, 81:11322-11331.
35. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803-809.
36. Hatziioannou T., Ambrose Z., Chung N.P., Piatak M., Yuan F., Trubey C.M., Coalter V., Kiser R., Schneider D., Smedley J., Pung R., Gathuka M., Estes J.D., Veazey R.S., KewalRamani V.N., Lifson J.D., Bieniasz P.D. A macaque model of HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4425-4429.
37. Hatziioannou T., Princiotta M., Piatak M., Yuan F., Zhang F., Lifson J.D., Bieniasz P.D. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 2006, 314:95.
38. Hauser H., Lopez L.A., Yang S.J., Oldenburg J.E., Exline C.M., Guatelli J.C., Cannon P.M. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 2010, 7:51.
39. Holmes R.K., Koning F.A., Bishop K.N., Malim M.H. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 2007, 282:2587-2595.
40. Hu C., Saenz D.T., Fadel H.J., Walker W., Peretz M., Poeschla E.M. The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F. J. Virol. 2010, 84:11981-11993.
41. Huthoff H., Towers G.J. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol. 2008, 16:612-619.
42. Igarashi T., Iyengar R., Byrum R.A., Buckler-White A., Dewar R.L., Buckler C.E., Lane H.C., Kamada K., Adachi A., Martin M.A. Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques. J. Virol. 2007, 81:11549-11552.
43. Iwatani Y., Chan D.S., Wang F., Maynard K.S., Sugiura W., Gronenborn A.M., Rouzina I., Williams M.C., Musier-Forsyth K., Levin J.G. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 2007, 35:7096-7108.
44. Jarrett O., Laird H.M., Hay D., Crighton G.W. Replication of cat leukemia virus in cell cultures. Nature 1968, 219:521-522.
45. Jouvenet N., Neil S.J., Zhadina M., Zang T., Kratovac Z., Lee Y., McNatt M., Hatziioannou T., Bieniasz P.D. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 2009, 83:1837-1844.
46. Kaletsky R.L., Francica J.R., Agrawal-Gamse C., Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2886-2891.
47. Kamada K., Igarashi T., Martin M.A., Khamsri B., Hatcho K., Yamashita T., Fujita M., Uchiyama T., Adachi A. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16959-16964.
48. Katzourakis A., Tristem M., Pybus O.G., Gifford R.J. Discovery and analysis of the first endogenous lentivirus. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6261-6265.
49. Keckesova Z., Ylinen L.M., Towers G.J. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10780-10785.
50. Keckesova Z., Ylinen L.M., Towers G.J., Gifford R.J., Katzourakis A. Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 2009, 384:7-11.
51. Keppler O.T., Welte F.J., Ngo T.A., Chin P.S., Patton K.S., Tsou C.L., Abbey N.W., Sharkey M.E., Grant R.M., You Y., Scarborough J.D., Ellmeier W., Littman D.R., Stevenson M., Charo I.F., Herndier B.G., Speck R.F., Goldsmith M.A. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp Med. 2002, 195:719-736.
52. Keppler O.T., Yonemoto W., Welte F.J., Patton K.S., Iacovides D., Atchison R.E., Ngo T., Hirschberg D.L., Speck R.F., Goldsmith M.A. Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 2001, 75:8063-8073.
53. Kestler H., Kodama T., Ringler D., Marthas M., Pedersen N., Lackner A., Regier D., Sehgal P., Daniel M., King N., et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 1990, 248:1109-1112.
54. Kestler H.W., Ringler d., Mori D.J., Panicali K., Sehgal D.L., Daniel P.K., Desrosiers M.D.R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65:651-662.
55. Khan M.A., Kao S., Miyagi E., Takeuchi H., Goila-Gaur R., Opi S., Gipson C.L., Parslow T.G., Ly H., Strebel K. Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes. J. Virol. 2005, 79:5870-5874.
56. Kirchhoff F. Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution?. Nat. Rev. Microbiol. 2009, 7:467-476.
57. Kirmaier A., Wu F., Newman R.M., Hall L.R., Morgan J.S., O'Connor S., Marx P.A., Meythaler M., Goldstein S., Buckler-White A., Kaur A., Hirsch V.M., Johnson W.E. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 2010, 8.
58. Koito A., Kameyama Y., Cheng-Mayer C., Matsushita S. Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 2003, 77:5109-5117.
59. Koito A., Shigekane H., Matsushita S. Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication. Virology 2003, 305:181-191.
60. Kolchinsky P., Mirzabekov T., Farzan M., Kiprilov E., Cayabyab M., Mooney L.J., Choe H., Sodroski J. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication. J. Virol. 1999, 73:8120-8126.
61. Koning F.A., Newman E.N., Kim E.Y., Kunstman K.J., Wolinsky S.M., Malim M.H. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 2009, 83:9474-9485.
62. LaRue R.S., Andresdottir V., Blanchard Y., Conticello S.G., Derse D., Emerman M., Greene W.C., Jonsson S.R., Landau N.R., Lochelt M., Malik H.S., Malim M.H., Munk C., O'Brien S.J., Pathak V.K., Strebel K., Wain-Hobson S., Yu X.F., Yuhki N., Harris R.S. Guidelines for naming nonprimate APOBEC3 genes and proteins. J. Virol. 2009, 83:494-497.
63. LaRue R.S., Jonsson S.R., Silverstein K.A., Lajoie M., Bertrand D., El-Mabrouk N., Hotzel I., Andresdottir V., Smith T.P., Harris R.S. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol. 2008, 9:104.
64. LaRue R.S., Lengyel J., Jonsson S.R., Andresdottir V., Harris R.S. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J. Virol. 2010, 84:8193-8201.
65. Le Tortorec A., Neil S.J. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 2009, 83:11966-11978.
66. Letvin N.L., Daniel M.D., Sehgal P.K., Desrosiers R.C., Hunt R.D., Waldron L.M., MacKey J.J., Schmidt D.K., Chalifoux L.V., King N.W. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985, 230:71-73.
67. Li X.Y., Guo F., Zhang L., Kleiman L., Cen S. APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. J. Biol. Chem. 2007, 282:32065-32074.
68. Liao C.H., Kuang Y.Q., Liu H.L., Zheng Y.T., Su B. A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection. AIDS 2007, 21(Suppl. 8):S19-26.
69. Lim E.S., Emerman M. Simian immunodeficiency virus SIVagm from African green monkeys does not antagonize endogenous levels of African green monkey tetherin/BST-2. J. Virol. 2009, 83:11673-11681.
70. Lim E.S., Malik H.S., Emerman M. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J. Virol. 2010, 84:7124-7134.
71. Lim S.Y., Rogers T., Chan T., Whitney J.B., Kim J., Sodroski J., Letvin N.L. TRIM5alpha modulates immunodeficiency virus control in rhesus monkeys. PLoS Pathog. 2010, 6:e1000738.
72. Lochelt M., Romen F., Bastone P., Muckenfuss H., Kirchner N., Kim Y.B., Truyen U., Rosler U., Battenberg M., Saib A., Flory E., Cichutek K., Munk C. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7982-7987.
73. Luban J. Cyclophilin A TRIM5, and resistance to human immunodeficiency virus type 1 infection. J. Virol. 2007, 81:1054-1061.
74. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73:1067-1078.
75. Luo K., Liu B., Xiao Z., Yu Y., Yu X., Gorelick R., Yu X.F. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J. Virol. 2004, 78:11841-11852.
76. Malim M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2009, 364:675-687.
77. Malim M.H., Emerman M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 2008, 3:388-398.
78. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
79. Mansouri M., Viswanathan K., Douglas J.L., Hines J., Gustin J., Moses A.V., Fruh K. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2009, 83:9672-9681.
80. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003, 114:21-31.
81. Mariani R., Rasala B.A., Rutter G., Wiegers K., Brandt S.M., Krausslich H.G., Landau N.R. Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly. J. Virol. 2001, 75:3141-3151.
82. Marin M., Rose K.M., Kozak S.L., Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 2003, 9:1398-1403.
83. Mbisa J.L., Barr R., Thomas J.A., Vandegraaff N., Dorweiler I.J., Svarovskaia E.S., Brown W.L., Mansky L.M., Gorelick R.J., Harris R.S., Engelman A., Pathak V.K. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J. Virol. 2007, 81:7099-7110.
84. McEwan W.A., Schaller T., Ylinen L.M., Hosie M.J., Towers G.J., Willett B.J. Truncation of TRIM5 in Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J. Virol. 2009, 16:8270-8275.
85. McKnight A., Clapham P.R., Weiss R.A. HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology 1994, 201:8-18.
86. Mehle A., Strack B., Ancuta P., Zhang C., McPike M., Gabuzda D. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem 2004, 279:7792-7798.
87. Michel N., Goffinet C., Ganter K., Allespach I., Kewalramani V.N., Saifuddin M., Littman D.R., Greene W.C., Goldsmith M.A., Keppler O.T. Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo. Retrovirology 2009, 6:2.
88. Mische C.C., Javanbakht H., Song B., Diaz-Griffero F., Stremlau M., Strack B., Si Z., Sodroski J. Retroviral restriction factor TRIM5alpha is a trimer. J. Virol. 2005, 79:14446-14450.
89. Miyagi E., Opi S., Takeuchi H., Khan M., Goila-Gaur R., Kao S., Strebel K. Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1. J. Virol. 2007, 81:13346-13353.
90. Münk C., Beck T., Zielonka J., Hotz-Wagenblatt A., Chareza S., Battenberg M., Thielebein J., Cichutek K., Bravo I.G., O'Brien S.J., Lochelt M., Yuhki N. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 2008, 9:R48.
91. Munk C., Hechler T., Chareza S., Lochelt M. Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins. Vet. Immunol. Immunopathol. 2009, 134:14-24.
92. Münk C., Zielonka J., Constabel H., Kloke B.P., Rengstl B., Battenberg M., Bonci F., Pistello M., Lochelt M., Cichutek K. Multiple restrictions of human immunodeficiency virus type 1 in feline cells. J. Virol. 2007, 81:7048-7060.
93. Naidu Y.M., Kestler H.W., Li Y., Butler C.V., Silva D.P., Schmidt D.K., Troup C.D., Sehgal P.K., Sonigo P., Daniel M.D., et al. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 1988, 62:4691-4696.
94. Navarro F., Bollman B., Chen H., Konig R., Yu Q., Chiles K., Landau N.R. Complementary function of the two catalytic domains of APOBEC3G. Virology 2005, 333:374-386.
95. Neagu M.R., Ziegler P., Pertel T., Strambio-De-Castillia C., Grutter C., Martinetti G., Mazzucchelli L., Grutter M., Manz M.G., Luban J. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J. Clin Invest. 2009, 119:3035-3047.
96. Neil S.J., Sandrin V., Sundquist W.I., Bieniasz P.D. An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2007, 2:193-203.
97. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
98. Newman E.N., Holmes R.K., Craig H.M., Klein K.C., Lingappa J.R., Malim M.H., Sheehy A.M. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 2005, 15:166-170.
99. Newman R.M., Hall L., Kirmaier A., Pozzi L.A., Pery E., Farzan M., O'Neil S.P., Johnson W. Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog. 2008, 4:e1000003.
100. Nisole S., Lynch C., Stoye J.P., Yap M.W. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13324-13328.
101. Nisole S., Stoye J.P., Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3:799-808.
102. OhAinle M., Kerns J.A., Malik H.S., Emerman M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J. Virol. 2006, 80:3853-3862.
103. Pacheco B., Basmaciogullari S., Labonte J.A., Xiang S.H., Sodroski J. Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to new world monkey receptors. J. Virol. 2008, 82:346-357.
104. Pecon-Slattery J., Troyer J.L., Johnson W.E., O'Brien S.J. Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology. Vet. Immunol. Immunopathol. 2008, 123:32-44.
105. Pedersen N.C., Ho E.W., Brown M.L., Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987, 235:790-793.
106. Perez-Caballero D., Hatziioannou T., Zhang F., Cowan S., Bieniasz P.D. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J. Virol. 2005, 79:15567-15572.
107. Perez-Caballero D., Zang T., Ebrahimi A., McNatt M.W., Gregory D.A., Johnson M.C., Bieniasz P.D. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511.
108. Perkovic M., Schmidt S., Marino D., Russell R.A., Stauch B., Hofmann H., Kopietz F., Kloke B.P., Zielonka J., Strover H., Hermle J., Lindemann D., Pathak V.K., Schneider G., Lochelt M., Cichutek K., Munk C. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J. Biol. Chem. 2009, 284:5819-5826.
109. Perron M.J., Stremlau M., Lee M., Javanbakht H., Song B., Sodroski J. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J. Virol. 2007, 81:2138-2148.
110. Poeschla E., Looney D. CXCR4 is required by a non-primate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent and feline cells. J. Virol. 1998, 72:6858-6866.
111. Polani S., Roca A.L., Rosensteel B.B., Kolokotronis S.O., Bar-Gal G.K. Evolutionary dynamics of endogenous feline leukemia virus proliferation among species of the domestic cat lineage. Virology 2010, 405:397-407.
112. Refsland E.W., Stenglein M.D., Shindo K., Albin J.S., Brown W.L., Harris R.S. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010, 38:4274-4284.
113. Roca A.L., Pecon-Slattery J., O'Brien S.J. Genomically intact endogenous feline leukemia viruses of recent origin. J. Virol. 2004, 78:4370-4375.
114. Roelke M.E., Brown M.A., Troyer J.L., Winterbach H., Winterbach C., Hemson G., Smith D., Johnson R.C., Pecon-Slattery J., Roca A.L., Alexander K.A., Klein L., Martelli P., Krishnasamy K., O'Brien S.J. Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions. Virology 2009, 390:1-12.
115. Roelke M.E., Pecon-Slattery J., Taylor S., Citino S., Brown E., Packer C., Vandewoude S., O'Brien S.J. T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion. J. Wildl. Dis. 2006, 42:234-248.
116. Saenz D.T., Teo W., Olsen J.C., Poeschla E. Restriction of feline immunodeficiency virus by Ref1, LV1 and primate TRIM5α proteins. J. Virol. 2005, 79:15175-15188.
117. Sakuma R., Mael A.A., Ikeda Y. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 2007, 81:10201-10206.
118. Sakuma T., Noda T., Urata S., Kawaoka Y., Yasuda J. Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 2009, 83:2382-2385.
119. Sarma P.S., Tseng J., Lee Y.K., Gilden R.V. Virus similar to RD114 virus in cat cells. Nat. New Biol. 1973, 244:56-59.
120. Sauter D., Schindler M., Specht A., Landford W.N., Munch J., Kim K.A., Votteler J., Schubert U., Bibollet-Ruche F., Keele B.F., Takehisa J., Ogando Y., Ochsenbauer C., Kappes J.C., Ayouba A., Peeters M., Learn G.H., Shaw G., Sharp P.M., Bieniasz P., Hahn B.H., Hatziioannou T., Kirchhoff F. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009, 6:409-421.
121. Sawyer S.L., Emerman M., Malik H.S. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2004, 2:E275.
122. Sawyer S.L., Emerman M., Malik H.S. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 2007, 3:e197.
123. Sawyer S.L., Wu L.I., Emerman M., Malik H.S. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2832-2837.
124. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
125. Schafer A., Bogerd H.P., Cullen B.R. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology 2004, 328:163-168.
126. Schaller T., Hue S., Towers G.J. An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J. Virol. 2007, 81:11713-11721.
127. Schumacher A.J., Hache G., Macduff D.A., Brown W.L., Harris R.S. The DNA deaminase activity of human APOBEC3G is required for Ty1 MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 2008, 82:2652-2660.
128. Sebastian S., Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40.
129. Sharp P.M., Hahn B.H. The evolution of HIV-1 and the origin of AIDS. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2010, 365:2487-2494.
130. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
131. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 2003, 9:1404-1407.
132. Shibata R., Kawamura M., Sakai H., Hayami M., Ishimoto A., Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 1991, 65:3514-3520.
133. Shimojima M., Miyazawa T., Ikeda Y., McMonagle E.L., Haining H., Akashi H., Takeuchi Y., Hosie M.J., Willett B.J. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 2004, 303:1192-1195.
134. Si Z., Vandegraaff N., O'Huigin C., Song B., Yuan W., Xu C., Perron M., Li X., Marasco W.A., Engelman A., Dean M., Sodroski J. Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7454-7459.
135. Sigurdsson B., Palsson P.A., Grimsson H. Visna: a demyelinating transmissbile disease of sheep. J. Neuropathol. Exp. Neurol. 1957, 16:389-403.
136. Sokolskaja E., Luban J. Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr. Opin. Microbiol. 2006, 9:404-408.
137. Stern M.A., Hu C., Saenz D.T., Fadel H.J., Sims O., Peretz M., Poeschla E.M. Productive replication of Vif-chimeric HIV-1 in feline cells. J. Virol. 2010, 84:7378-7395.
138. Stopak K., de Noronha C., Yonemoto W., Greene W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 2003, 12:591-601.
139. Stoye J.P., Yap M.W. Chance favors a prepared genome. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3177-3178.
140. Strebel K., Luban J., Jeang K.T. Human cellular restriction factors that target HIV-1 replication. BMC Med. 2009, 7:48.
141. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
142. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5514-5519.
143. Stremlau M., Song B., Javanbakht H., Perron M., Sodroski J. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. Virology 2006, 351:112-120.
144. Svarovskaia E.S., Xu H., Mbisa J.L., Barr R., Gorelick R.J., Ono A., Freed E.O., Hu W.S., Pathak V.K. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J. Biol. Chem. 2004, 279:35822-35828.
145. Swanson C.M., Puffer B.A., Ahmad K.M., Doms R.W., Malim M.H. Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J. 2004, 23:2632-2640.
146. Tervo H.M., Goffinet C., Keppler O.T. Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration. Retrovirology 2008, 5:58.
147. Tervo H.M., Keppler O.T. High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier. J. Virol. 2010, 84:12300-12314.
148. Tokarev A., Skasko M., Fitzpatrick K., Guatelli J. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin. AIDS Res. Hum. Retroviruses 2009, 25:1197-1210.
149. Towers G., Bock M., Martin S., Takeuchi Y., Stoye J.P., Danos O. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:12295-12299.
150. Towers G.J. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007, 4:40.
151. Towers G.J., Hatziioannou T., Cowan S., Goff S.P., Luban J., Bieniasz P.D. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 2003, 9:1138-1143.
152. Troyer J.L., Vandewoude S., Pecon-Slattery J., McIntosh C., Franklin S., Antunes A., Johnson W., O'Brien S.J. FIV cross-species transmission: an evolutionary prospective. Vet. Immunol. Immunopathol. 2008, 123:159-166.
153. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
154. van Valen L. A new evolutionary law. Evol. Theory 1973, 1:1-30.
155. Virgen C.A., Kratovac Z., Bieniasz P.D., Hatziioannou T. Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3563-3568.
156. Wei P., Garber M.E., Fang S.M., Fischer W.H., Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462.
157. Willett B.J., Hosie M.J., Neil J.C., Turner J.D., Hoxie J.A. Common mechanism of infection by lentiviruses. Nature 1997, 385:587.
158. Willett B.J., McMonagle E.L., Ridha S., Hosie M.J. Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus. J. Virol. 2006, 80:3386-3394.
159. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 1997, 71:6407-6415.
160. Wilson S.J., Webb B.L., Ylinen L.M., Verschoor E., Heeney J.L., Towers G.J. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3557-3562.
161. Winkler I., Bodem J., Haas L., Zemba M., Delius H., Flower R., Flugel R.M., Lochelt M. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 1997, 71:6727-6741.
162. Wu X., Anderson J.L., Campbell E.M., Joseph A.M., Hope T.J. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7465-7470.
163. Xu H., Svarovskaia E.S., Barr R., Zhang Y., Khan M.A., Strebel K., Pathak V.K. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5652-5657.
164. Yang S.J., Lopez L.A., Hauser H., Exline C.M., Haworth K.G., Cannon P.M. Anti-tetherin activities in Vpu-expressing primate lentiviruses. Retrovirology 2010, 7:13.
165. Ylinen L.M., Keckesova Z., Webb B.L., Gifford R.J., Smith T.P., Towers G.J. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J. Virol. 2006, 80:7332-7338.
166. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302:1056-1060.
167. Zennou V., Perez-Caballero D., Gottlinger H., Bieniasz P.D. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J. Virol. 2004, 78:12058-12061.
168. Zhang F., Wilson S.J., Landford W.C., Virgen B., Gregory D., Johnson M.C., Munch J., Kirchhoff F., Bieniasz P.D., Hatziioannou T. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009, 6:54-67.
169. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
170. Zielonka J., Marino D., Hofmann H., Yuhki N., Lochelt M., Munk C. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J. Virol. 2010, 84:7312-7324.